LOKI FÜR HUMANISIERTES IMMUNOGLOBULIN

European patent · EP1644417 · Deleted

Register entry

Publication number
EP1644417
Application number
EP04778633
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Jul 15, 2004
Published
Apr 12, 2006
Granted
Apr 30, 2014
Deleted
Jul 15, 2024
Reason
Maximum term reached
IPC classes
C07K 16/46 (2006.01)
Priority
US 487733 P 15.07.2003
PCT application
PCT/US2004/023226 15.07.2004
PCT publication
WO2005/007696 27.01.2005
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 15, 2024

    Maximum term reached

    Published in Swissreg on 15.07.2024

  2. Aug 1, 2023

    Change

    Published in Swissreg on 01.08.2023

  3. Aug 1, 2022

    Change

    Published in Swissreg on 01.08.2022

  4. Apr 30, 2014

    Granted

    Published in Swissreg on 30.04.2014

Parties

Holder

Therapeutic Human Polyclonals, Inc.

3431 Hillview Avenue, Palo Alto, CA 94304, US

Inventor

BUELOW, Roland

Palo Alto, CA 94303, US

VAN SCHOOTEN, Wim

Sunnyvale, CA 94087, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.